1. Home
  2. CVRX vs FISI Comparison

CVRX vs FISI Comparison

Compare CVRX & FISI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CVRX
  • FISI
  • Stock Information
  • Founded
  • CVRX 2000
  • FISI 1817
  • Country
  • CVRX United States
  • FISI United States
  • Employees
  • CVRX N/A
  • FISI N/A
  • Industry
  • CVRX Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • FISI Major Banks
  • Sector
  • CVRX Health Care
  • FISI Finance
  • Exchange
  • CVRX Nasdaq
  • FISI Nasdaq
  • Market Cap
  • CVRX 419.8M
  • FISI 416.6M
  • IPO Year
  • CVRX 2021
  • FISI 1999
  • Fundamental
  • Price
  • CVRX $17.62
  • FISI $26.97
  • Analyst Decision
  • CVRX Strong Buy
  • FISI Hold
  • Analyst Count
  • CVRX 7
  • FISI 3
  • Target Price
  • CVRX $17.00
  • FISI $26.67
  • AVG Volume (30 Days)
  • CVRX 213.8K
  • FISI 131.4K
  • Earning Date
  • CVRX 01-27-2025
  • FISI 01-30-2025
  • Dividend Yield
  • CVRX N/A
  • FISI 4.45%
  • EPS Growth
  • CVRX N/A
  • FISI N/A
  • EPS
  • CVRX N/A
  • FISI 3.17
  • Revenue
  • CVRX $47,255,000.00
  • FISI $216,605,000.00
  • Revenue This Year
  • CVRX $31.78
  • FISI N/A
  • Revenue Next Year
  • CVRX $26.42
  • FISI $18.29
  • P/E Ratio
  • CVRX N/A
  • FISI $8.50
  • Revenue Growth
  • CVRX 34.38
  • FISI 9.25
  • 52 Week Low
  • CVRX $6.40
  • FISI $16.29
  • 52 Week High
  • CVRX $29.23
  • FISI $29.34
  • Technical
  • Relative Strength Index (RSI)
  • CVRX 76.79
  • FISI 51.43
  • Support Level
  • CVRX $13.82
  • FISI $26.40
  • Resistance Level
  • CVRX $17.72
  • FISI $27.50
  • Average True Range (ATR)
  • CVRX 0.88
  • FISI 0.70
  • MACD
  • CVRX 0.49
  • FISI -0.00
  • Stochastic Oscillator
  • CVRX 98.09
  • FISI 66.16

About CVRX CVRx Inc.

CVRx Inc is a commercial-stage medical device company focused on developing, manufacturing, and commercializing minimally invasive neuromodulation solutions for patients with cardiovascular diseases. Its proprietary platform technology, Barostim, is designed to leverage the power of the brain to address the imbalance of the Autonomic Nervous System, which causes heart failure and other cardiovascular diseases. Barostim provides Baroreflex Activation Therapy which in turn triggers an autonomic response to the heart. The majority of revenue is derived from the USA market.

About FISI Financial Institutions Inc.

Financial Institutions Inc operates as a financial holding company, engages in the provision of a wide range of consumer and commercial banking services to individuals, municipalities, and businesses in Western and Central New York. It operates through one segment: The Banking segment which includes all of the company's retail and commercial banking operations.

Share on Social Networks: